Navigation Links
InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
Date:3/20/2009

WALTHAM, Mass. and NEW YORK, March 20 /PRNewswire/ -- InnoCentive, Inc., the global open innovation marketplace, and Nature Publishing Group (NPG), a leading scientific and medical publisher, today announced a partnership to facilitate greater scientific collaboration and open innovation.

Under the agreement, InnoCentive and NPG will work together to stimulate the involvement of scientists worldwide in solving global scientific challenges, via an online marketplace for problems and their solutions. The concept of "open innovation" addresses the research challenges that organizations face, by using external expertise to solve problems and drive development of new products and technologies. Global challenges such as the development of better protection against malaria, finding ways to shorten the clinical trials process and the design of environmentally friendly, sustainable product packaging, to name a few, require broad and diverse expertise.

InnoCentive's open innovation web site provides a platform for organizations, companies and government agencies (known as 'Seekers') to post innovation 'Challenges' for the public (known as 'Solvers') to solve for financial reward. NPG and InnoCentive intend to jointly produce an online platform for open innovation challenges in the coming months, to facilitate the participation of NPG's large expert audience.

"NPG's flagship journal Nature has for nearly 150 years been at the forefront of bringing significant advances in science to the attention of the research community and the public, and strives to be an integral part of the scientific community, aiding collaboration and the spread of knowledge. For large global challenges like infectious diseases and climate change, it makes sense to cast the net as wide as possible to find experts who can solve a problem," said Steven Inchcoombe, Managing Director, Nature Publishing Group. "Through this partnership with InnoCentive, Nature Publishing Group hopes to explore how we can help increase the chance of solving these global problems. We look forward to working with InnoCentive to promote the expertise of scientists and bring benefits to the wider community."

This agreement comes at a pivotal time when businesses, especially those in life sciences, are endeavoring to maintain research and development activities with reduced budgets and resources. The partnership of NPG and InnoCentive will accelerate the uptake of open innovation as a complementary business model that has particular appeal during a global economic downturn.

"Nature is one of the most well-known scientific publications on the market and this partnership boosts awareness of the benefits of open innovation within the scientific community," said Dwayne Spradlin, CEO of InnoCentive, Inc. "It is imperative for companies to engage in open innovation for many reasons, including cost savings and improving lead times to development. Nature Publishing Group has been a pioneer in their use of Web 2.0 tools to interact with their community. We look forward to working with them."

Further details will be announced in due course.

About Nature Publishing Group (NPG):

Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, and a range of prestigious academic journals including society-owned publications. NPG also provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs.

In recent years, NPG has developed a reputation for innovation, using Web 2.0 technologies to foster new forms of scientific communication and collaboration. Examples include the social bookmarking service Connotea, which enables researchers to share, find, and organize articles of interest. Meanwhile, NPG's professional networking website for scientists, Nature Network, helps scientists to meet, communicate and collaborate.

NPG is a global company with principal offices in London, New York and Tokyo and offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.

About InnoCentive

Founded in 2001, InnoCentive built the first global web community for open innovation, enabling scientists, engineers, professionals and entrepreneurs to collaborate to deliver breakthrough solutions for R&D-driven organizations. InnoCentive Seekers, who collectively spend billions of dollars on R&D, submit complex problems to the InnoCentive Marketplace where more than 170,000 engineers, scientists, inventors, business people, and research organizations in more than 175 countries are invited to solve them. Solvers who deliver the most innovative solutions receive financial awards ranging up to US$1,000,000. InnoCentive's Seekers include commercial, government and non-profit organizations such as Avery Dennison, Procter & Gamble, Pendulum, Eli Lilly and Company, Janssen, Solvay, SAP and The Rockefeller Foundation.

For more information on InnoCentive, go to: www.innocentive.com.

InnoCentive and InnoCentive Challenge are registered trademarks of InnoCentive, Inc. Other product or service names mentioned herein are the trademarks of their respective owners.

    For more information contact:
    Grace Baynes
    Corporate Public Relations, Nature Publishing Group
    +44 (0)20 7014 4063
    g.baynes@nature.com

    Connie French
    InnoCentive Marketing Director
    978-482-3300
    press@innocentive.com


'/>"/>
SOURCE InnoCentive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Brain Signature for Cigarette Cravings Identified
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. InVitrias Cellastim Showcased in Nature Article
7. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
11. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):